Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Saxagliptin Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 13,826Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Dr. Reddy's Laboratories

    02 2Amneal Pharmaceuticals

    03 2Apotex Inc

    04 18AstraZeneca

    05 2Aurobindo Pharma Limited

    06 2Glenmark Pharmaceuticals

    07 2Sandoz B2B

    08 5Sun Pharmaceutical Industries Limited

    09 5Viatris

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Dr. Reddy's Laboratories

    India
    arrow
    CPhI India 2024
    Booth #RH.E02
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 500MG;EQ 5MG BASE

    Packaging :

    Approval Date : 2023-08-09

    Application Number : 207678

    Regulatory Info : RX

    Registration Country : USA

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Dr. Reddy's Laboratories

    India
    arrow
    CPhI India 2024
    Booth #RH.E02
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 1GM;EQ 2.5MG BASE

    Packaging :

    Approval Date : 2023-08-09

    Application Number : 207678

    Regulatory Info : RX

    Registration Country : USA

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Dr. Reddy's Laboratories

    India
    arrow
    CPhI India 2024
    Booth #RH.E02
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 1GM;EQ 5MG BASE

    Packaging :

    Approval Date : 2023-08-09

    Application Number : 207678

    Regulatory Info : RX

    Registration Country : USA

    Dr Reddy Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Amneal Pharmaceuticals

    U.S.A
    CPhI India 2024
    Not Confirmed
    arrow

    Amneal Pharmaceuticals

    U.S.A
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : SAXAGLIPTIN

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 2.5MG BASE

    Packaging :

    Approval Date : 2023-07-31

    Application Number : 205941

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Amneal Pharmaceuticals

    U.S.A
    CPhI India 2024
    Not Confirmed
    arrow

    Amneal Pharmaceuticals

    U.S.A
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : SAXAGLIPTIN

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 5MG BASE

    Packaging :

    Approval Date : 2023-07-31

    Application Number : 205941

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    AstraZeneca

    United Kingdom
    CPhI India 2024
    Not Confirmed
    arrow

    AstraZeneca

    United Kingdom
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : ONGLYZA

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 2.5MG BASE

    Packaging :

    Approval Date : 2009-07-31

    Application Number : 22350

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    AstraZeneca

    United Kingdom
    CPhI India 2024
    Not Confirmed
    arrow

    AstraZeneca

    United Kingdom
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : ONGLYZA

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 5MG BASE

    Packaging :

    Approval Date : 2009-07-31

    Application Number : 22350

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    AstraZeneca

    United Kingdom
    CPhI India 2024
    Not Confirmed
    arrow

    AstraZeneca

    United Kingdom
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : KOMBIGLYZE XR

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 500MG;EQ 5MG BASE

    Packaging :

    Approval Date : 2010-11-05

    Application Number : 200678

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    AstraZeneca

    United Kingdom
    CPhI India 2024
    Not Confirmed
    arrow

    AstraZeneca

    United Kingdom
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : KOMBIGLYZE XR

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 1GM;EQ 5MG BASE

    Packaging :

    Approval Date : 2010-11-05

    Application Number : 200678

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    AstraZeneca

    United Kingdom
    CPhI India 2024
    Not Confirmed
    arrow

    AstraZeneca

    United Kingdom
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : KOMBIGLYZE XR

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 1GM;EQ 2.5MG BASE

    Packaging :

    Approval Date : 2010-11-05

    Application Number : 200678

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    11

    AstraZeneca

    United Kingdom
    CPhI India 2024
    Not Confirmed
    arrow

    AstraZeneca

    United Kingdom
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : QTERN

    Dosage Form : TABLET;ORAL

    Dosage Strength : 10MG;EQ 5MG BASE

    Packaging :

    Approval Date : 2017-02-27

    Application Number : 209091

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    12

    AstraZeneca

    United Kingdom
    CPhI India 2024
    Not Confirmed
    arrow

    AstraZeneca

    United Kingdom
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : QTERN

    Dosage Form : TABLET;ORAL

    Dosage Strength : 5MG;EQ 5MG BASE

    Packaging :

    Approval Date : 2019-05-02

    Application Number : 209091

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    13

    AstraZeneca

    United Kingdom
    CPhI India 2024
    Not Confirmed
    arrow

    AstraZeneca

    United Kingdom
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : QTERNMET XR

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 2.5MG;1GM;EQ 2.5MG BASE

    Packaging :

    Approval Date : 2019-05-02

    Application Number : 210874

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    14

    AstraZeneca

    United Kingdom
    CPhI India 2024
    Not Confirmed
    arrow

    AstraZeneca

    United Kingdom
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : QTERNMET XR

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 5MG;1GM;EQ 2.5MG BASE

    Packaging :

    Approval Date : 2019-05-02

    Application Number : 210874

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    15

    AstraZeneca

    United Kingdom
    CPhI India 2024
    Not Confirmed
    arrow

    AstraZeneca

    United Kingdom
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : QTERNMET XR

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 5MG;1GM;EQ 5MG BASE

    Packaging :

    Approval Date : 2019-05-02

    Application Number : 210874

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    16

    AstraZeneca

    United Kingdom
    CPhI India 2024
    Not Confirmed
    arrow

    AstraZeneca

    United Kingdom
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : DISCN

    Registration Country : USA

    DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : QTERNMET XR

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 10MG;1GM;EQ 5MG BASE

    Packaging :

    Approval Date : 2019-05-02

    Application Number : 210874

    Regulatory Info : DISCN

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    17

    Aurobindo Pharma Limited

    India
    CPhI India 2024
    Not Confirmed
    arrow

    Aurobindo Pharma Limited

    India
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : SAXAGLIPTIN

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 2.5MG BASE

    Packaging :

    Approval Date : 2023-07-31

    Application Number : 205972

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    18

    Aurobindo Pharma Limited

    India
    CPhI India 2024
    Not Confirmed
    arrow

    Aurobindo Pharma Limited

    India
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : SAXAGLIPTIN

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 5MG BASE

    Packaging :

    Approval Date : 2023-07-31

    Application Number : 205972

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    19

    Glenmark Pharmaceuticals

    India
    CPhI India 2024
    Not Confirmed
    arrow

    Glenmark Pharmaceuticals

    India
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : SAXAGLIPTIN

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 2.5MG BASE

    Packaging :

    Approval Date : 2023-07-31

    Application Number : 205994

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    20

    Glenmark Pharmaceuticals

    India
    CPhI India 2024
    Not Confirmed
    arrow

    Glenmark Pharmaceuticals

    India
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : SAXAGLIPTIN

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 5MG BASE

    Packaging :

    Approval Date : 2023-07-31

    Application Number : 205994

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    21

    Sun Pharmaceutical Industries Limit...

    India
    CPhI India 2024
    Not Confirmed
    arrow

    Sun Pharmaceutical Industries Limit...

    India
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : SAXAGLIPTIN

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 2.5MG BASE

    Packaging :

    Approval Date : 2023-07-31

    Application Number : 206078

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    22

    Sun Pharmaceutical Industries Limit...

    India
    CPhI India 2024
    Not Confirmed
    arrow

    Sun Pharmaceutical Industries Limit...

    India
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : SAXAGLIPTIN

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 5MG BASE

    Packaging :

    Approval Date : 2023-07-31

    Application Number : 206078

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    23

    Sun Pharmaceutical Industries Limit...

    India
    CPhI India 2024
    Not Confirmed
    arrow

    Sun Pharmaceutical Industries Limit...

    India
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 500MG;EQ 5MG BASE

    Packaging :

    Approval Date : 2023-07-31

    Application Number : 206081

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    24

    Sun Pharmaceutical Industries Limit...

    India
    CPhI India 2024
    Not Confirmed
    arrow

    Sun Pharmaceutical Industries Limit...

    India
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 1GM;EQ 2.5MG BASE

    Packaging :

    Approval Date : 2023-07-31

    Application Number : 206081

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    25

    Sun Pharmaceutical Industries Limit...

    India
    CPhI India 2024
    Not Confirmed
    arrow

    Sun Pharmaceutical Industries Limit...

    India
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 1GM;EQ 5MG BASE

    Packaging :

    Approval Date : 2023-07-31

    Application Number : 206081

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    26

    Viatris

    U.S.A
    CPhI India 2024
    Not Confirmed
    arrow

    Viatris

    U.S.A
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : SAXAGLIPTIN

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 2.5MG BASE

    Packaging :

    Approval Date : 2023-07-31

    Application Number : 205980

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    27

    Viatris

    U.S.A
    CPhI India 2024
    Not Confirmed
    arrow

    Viatris

    U.S.A
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : SAXAGLIPTIN

    Dosage Form : TABLET;ORAL

    Dosage Strength : EQ 5MG BASE

    Packaging :

    Approval Date : 2023-07-31

    Application Number : 205980

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    28

    Viatris

    U.S.A
    CPhI India 2024
    Not Confirmed
    arrow

    Viatris

    U.S.A
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 500MG;EQ 5MG BASE

    Packaging :

    Approval Date : 2023-07-31

    Application Number : 205981

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    29

    Viatris

    U.S.A
    CPhI India 2024
    Not Confirmed
    arrow

    Viatris

    U.S.A
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 1GM;EQ 2.5MG BASE

    Packaging :

    Approval Date : 2023-07-31

    Application Number : 205981

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    30

    Viatris

    U.S.A
    CPhI India 2024
    Not Confirmed
    arrow

    Viatris

    U.S.A
    arrow
    CPhI India 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : RX

    Registration Country : USA

    METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 1GM;EQ 5MG BASE

    Packaging :

    Approval Date : 2023-07-31

    Application Number : 205981

    Regulatory Info : RX

    Registration Country : USA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF